Carotid stenosis: Endarterectomy or angioplasty and stenting?

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

Atherosclerotic narrowing of the proximal internal carotid artery is an important mechanism in ischemic stroke. Optimal medical management of internal carotid stenosis includes antiplatelet agent and statin administration, blood pressure reduction, weight control, and smoking cessation. Decisions regarding the use of invasive procedures to treat carotid disease - specifically carotid endarterectomy and carotid angioplasty and stenting - must weigh the long-term risk reduction in ipsilateral ischemic stroke against the immediate intervention risks. Clinical trials evaluating the benefits of carotid endarterectomy were conducted before widespread use of statins and newer blood pressure-lowering agents such as angiotensin-receptor blockers; it is unclear what impact this may have had on trial results. Regardless, carotid endarterectomy is clearly superior to medical therapy for patients with symptomatic severe stenosis. Conversely, the benefit from endarterectomy is muted in individuals with symptomatic moderate stenosis or asymptomatic stenosis, and decisions regarding surgical intervention must incorporate surgeon proficiency and patient comorbidity. Currently, there is a lack of evidence to support the use of carotid artery angioplasty and stenting in the routine management of carotid disease. Selected patients with severe symptomatic stenosis for whom endarterectomy cannot be safely performed may still benefit from endovascular management However, it is unlikely that asymptomatic patients or symptomatic patients with moderate stenosis considered at high risk for endarterectomy would benefit from any intervention.

Original languageEnglish (US)
Pages (from-to)451-462
Number of pages12
JournalCurrent Treatment Options in Neurology
Volume9
Issue number6
DOIs
StatePublished - Nov 1 2007

Fingerprint

Carotid Endarterectomy
Carotid Stenosis
Angioplasty
Pathologic Constriction
Endarterectomy
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Stroke
Blood Pressure
Angiotensin Receptor Antagonists
Platelet Aggregation Inhibitors
Internal Carotid Artery
Smoking Cessation
Risk Reduction Behavior
Disease Management
Carotid Arteries
Comorbidity
Weight Loss
Clinical Trials

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Carotid stenosis : Endarterectomy or angioplasty and stenting? / Switzer, Jeffrey A; Hess, David C.

In: Current Treatment Options in Neurology, Vol. 9, No. 6, 01.11.2007, p. 451-462.

Research output: Contribution to journalReview article

@article{d9959036f562402689c2c7729cf00f81,
title = "Carotid stenosis: Endarterectomy or angioplasty and stenting?",
abstract = "Atherosclerotic narrowing of the proximal internal carotid artery is an important mechanism in ischemic stroke. Optimal medical management of internal carotid stenosis includes antiplatelet agent and statin administration, blood pressure reduction, weight control, and smoking cessation. Decisions regarding the use of invasive procedures to treat carotid disease - specifically carotid endarterectomy and carotid angioplasty and stenting - must weigh the long-term risk reduction in ipsilateral ischemic stroke against the immediate intervention risks. Clinical trials evaluating the benefits of carotid endarterectomy were conducted before widespread use of statins and newer blood pressure-lowering agents such as angiotensin-receptor blockers; it is unclear what impact this may have had on trial results. Regardless, carotid endarterectomy is clearly superior to medical therapy for patients with symptomatic severe stenosis. Conversely, the benefit from endarterectomy is muted in individuals with symptomatic moderate stenosis or asymptomatic stenosis, and decisions regarding surgical intervention must incorporate surgeon proficiency and patient comorbidity. Currently, there is a lack of evidence to support the use of carotid artery angioplasty and stenting in the routine management of carotid disease. Selected patients with severe symptomatic stenosis for whom endarterectomy cannot be safely performed may still benefit from endovascular management However, it is unlikely that asymptomatic patients or symptomatic patients with moderate stenosis considered at high risk for endarterectomy would benefit from any intervention.",
author = "Switzer, {Jeffrey A} and Hess, {David C}",
year = "2007",
month = "11",
day = "1",
doi = "10.1007/s11940-007-0046-x",
language = "English (US)",
volume = "9",
pages = "451--462",
journal = "Current Treatment Options in Neurology",
issn = "1092-8480",
publisher = "Current Science, Inc.",
number = "6",

}

TY - JOUR

T1 - Carotid stenosis

T2 - Endarterectomy or angioplasty and stenting?

AU - Switzer, Jeffrey A

AU - Hess, David C

PY - 2007/11/1

Y1 - 2007/11/1

N2 - Atherosclerotic narrowing of the proximal internal carotid artery is an important mechanism in ischemic stroke. Optimal medical management of internal carotid stenosis includes antiplatelet agent and statin administration, blood pressure reduction, weight control, and smoking cessation. Decisions regarding the use of invasive procedures to treat carotid disease - specifically carotid endarterectomy and carotid angioplasty and stenting - must weigh the long-term risk reduction in ipsilateral ischemic stroke against the immediate intervention risks. Clinical trials evaluating the benefits of carotid endarterectomy were conducted before widespread use of statins and newer blood pressure-lowering agents such as angiotensin-receptor blockers; it is unclear what impact this may have had on trial results. Regardless, carotid endarterectomy is clearly superior to medical therapy for patients with symptomatic severe stenosis. Conversely, the benefit from endarterectomy is muted in individuals with symptomatic moderate stenosis or asymptomatic stenosis, and decisions regarding surgical intervention must incorporate surgeon proficiency and patient comorbidity. Currently, there is a lack of evidence to support the use of carotid artery angioplasty and stenting in the routine management of carotid disease. Selected patients with severe symptomatic stenosis for whom endarterectomy cannot be safely performed may still benefit from endovascular management However, it is unlikely that asymptomatic patients or symptomatic patients with moderate stenosis considered at high risk for endarterectomy would benefit from any intervention.

AB - Atherosclerotic narrowing of the proximal internal carotid artery is an important mechanism in ischemic stroke. Optimal medical management of internal carotid stenosis includes antiplatelet agent and statin administration, blood pressure reduction, weight control, and smoking cessation. Decisions regarding the use of invasive procedures to treat carotid disease - specifically carotid endarterectomy and carotid angioplasty and stenting - must weigh the long-term risk reduction in ipsilateral ischemic stroke against the immediate intervention risks. Clinical trials evaluating the benefits of carotid endarterectomy were conducted before widespread use of statins and newer blood pressure-lowering agents such as angiotensin-receptor blockers; it is unclear what impact this may have had on trial results. Regardless, carotid endarterectomy is clearly superior to medical therapy for patients with symptomatic severe stenosis. Conversely, the benefit from endarterectomy is muted in individuals with symptomatic moderate stenosis or asymptomatic stenosis, and decisions regarding surgical intervention must incorporate surgeon proficiency and patient comorbidity. Currently, there is a lack of evidence to support the use of carotid artery angioplasty and stenting in the routine management of carotid disease. Selected patients with severe symptomatic stenosis for whom endarterectomy cannot be safely performed may still benefit from endovascular management However, it is unlikely that asymptomatic patients or symptomatic patients with moderate stenosis considered at high risk for endarterectomy would benefit from any intervention.

UR - http://www.scopus.com/inward/record.url?scp=36049046403&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=36049046403&partnerID=8YFLogxK

U2 - 10.1007/s11940-007-0046-x

DO - 10.1007/s11940-007-0046-x

M3 - Review article

C2 - 18173944

AN - SCOPUS:36049046403

VL - 9

SP - 451

EP - 462

JO - Current Treatment Options in Neurology

JF - Current Treatment Options in Neurology

SN - 1092-8480

IS - 6

ER -